| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | | | Winrevair 45 mg | | PA | PA | k.A. | | Trockensubstanz: Sotaterceptum 45 mg | MSD Merck Sharp & Dohme AG | B | FB | | G |  |
| | FI | | | Winrevair 45 mg | 2 | PA | PA | k.A. | | Trockensubstanz: Sotaterceptum 45 mg | MSD Merck Sharp & Dohme AG | B | FB | | G |  |
| | FI | | | Winrevair 60 mg | | PA | PA | k.A. | | Trockensubstanz: Sotaterceptum 60 mg | MSD Merck Sharp & Dohme AG | B | FB | | G |  |
| | FI | | | Winrevair 60 mg | 2 | PA | PA | k.A. | | Trockensubstanz: Sotaterceptum 60 mg | MSD Merck Sharp & Dohme AG | B | FB | | G |  |
|
| | FI | PI | | Tracleer 62,5 mg | 56 Tablette(n) | 922.05 | 1013.50 | 10% | | Filmtabletten: Bosentanum 62.5 mg | Janssen-Cilag AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Tracleer 62,5 mg | 56 | 922.05 | 1013.50 | 10% | | Filmtabletten: Bosentanum 62.5 mg | Janssen-Cilag AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Tracleer 125 mg | 56 Tablette(n) | 922.05 | 1013.50 | 10% | | Filmtabletten: Bosentanum 125 mg | Janssen-Cilag AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Tracleer 125 mg | 56 | 922.05 | 1013.50 | 10% | | Filmtabletten: Bosentanum 125 mg | Janssen-Cilag AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Bosentan-Mepha 62.5 mg | 56 | 829.85 | 918.95 | 10% | | Filmtabletten: Bosentanum 62.5 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
| | FI | PI | | Bosentan-Mepha 125 mg | 56 | 829.85 | 918.95 | 10% | | Filmtabletten: Bosentanum 125 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
| | FI | PI | | Tracleer | 56 Tablette(n) | PA | PA | k.A. | | Dispersible Tabletten: Bosentanum 32 mg | Janssen-Cilag AG | B | FB | | G |  |
| | FI | PI | | Bosentan-Mepha 62.5 mg | 14 | PA | PA | k.A. | | Filmtabletten: Bosentanum 62.5 mg | Mepha Pharma AG | B | FB | | G |  |
| | FI | PI | | Bosentan-Mepha 125 mg | 14 | PA | PA | k.A. | | Filmtabletten: Bosentanum 125 mg | Mepha Pharma AG | B | FB | | G |  |
|
L | | FI | PI | | Volibris 5 mg | 30 Tablette(n) | 1089.60 | 1195.35 | 10% | | Filmtabletten: Ambrisentanum 5 mg | GlaxoSmithKline AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Volibris 10 mg | 30 Tablette(n) | 1089.60 | 1195.35 | 10% | | Filmtabletten: Ambrisentanum 10 mg | GlaxoSmithKline AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Ambrisentan Devatis 5 mg | 30 | 990.57 | 1093.70 | 10% | | Filmtabletten: Ambrisentanum 5 mg | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ambrisentan Devatis 10 mg | 30 | 990.57 | 1093.70 | 10% | | Filmtabletten: Ambrisentanum 10 mg | Devatis AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ambrisentan OrPha 5 mg | 30 | 990.57 | 1093.70 | 10% | | Filmtabletten: Ambrisentanum 5 mg | OrPha Swiss GmbH | B / SL / SG | FB | | G |  |
L | | FI | | | Ambrisentan OrPha 10 mg | 30 | 990.57 | 1093.70 | 10% | | Filmtabletten: Ambrisentanum 10 mg | OrPha Swiss GmbH | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ambrisentan-Mepha 5 mg | 30 | 990.57 | 1093.70 | 10% | | Filmtabletten: Ambrisentanum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ambrisentan-Mepha 10 mg | 30 | 990.57 | 1093.70 | 10% | | Filmtabletten: Ambrisentanum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Ambrisentan Devatis 5 mg | 10 | PA | PA | k.A. | | Filmtabletten: Ambrisentanum 5 mg | Devatis AG | B | FB | | G |  |
| | FI | | | Ambrisentan Devatis 10 mg | 10 | PA | PA | k.A. | | Filmtabletten: Ambrisentanum 10 mg | Devatis AG | B | FB | | G |  |
|
L | | FI | PI | PS | Opsumit 10 mg | 30 Tablette(n) | 2800.97 | 3062.65 | 10% | | Filmtabletten: Macitentanum 10 mg | Actelion Pharmaceuticals Ltd | B / SL | FB | | G |  |
|
L | | FI | PI | PS | Adempas 0.5 mg | 42 Tablette(n) | 1288.67 | 1417.90 | 10% | | Filmtabletten: Riociguatum | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 1 mg | 42 Tablette(n) | 1288.67 | 1417.90 | 10% | | Filmtabletten: Riociguatum 1 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 1.5 mg | 42 Tablette(n) | 1288.67 | 1417.90 | 10% | | Filmtabletten: Riociguatum 1.5 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 1.5 mg | 84 Tablette(n) | 2577.34 | 2819.45 | 10% | | Filmtabletten: Riociguatum 1.5 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 2 mg | 42 Tablette(n) | 1288.67 | 1417.90 | 10% | | Filmtabletten: Riociguatum 2 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 2 mg | 84 Tablette(n) | 2577.34 | 2819.45 | 10% | | Filmtabletten: Riociguatum 2 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 2.5 mg | 42 Tablette(n) | 1288.67 | 1417.90 | 10% | | Filmtabletten: Riociguatum 2.5 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Adempas 2.5 mg | 84 Tablette(n) | 2577.34 | 2819.45 | 10% | | Filmtabletten: Riociguatum 2.5 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
| | FI | PI | PS | Adempas 0.5 mg | 84 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Riociguatum | Bayer (Schweiz) AG | B | FB | | G |  |
| | FI | PI | PS | Adempas 1 mg | 84 Tablette(n) | 2577.34 | 2819.45 | k.A. | | Filmtabletten: Riociguatum 1 mg | Bayer (Schweiz) AG | B | FB | | G |  |
|
L | | FI | PI | | Winrevair 45 mg | | 5956.94 | 6419.60 | 10% | | Lyophilisat und Lösungsmittel: Sotaterceptum 45 mg | MSD Merck Sharp & Dohme AG | B / SL | FB | | G |  |
L | | FI | PI | | Winrevair 45 mg | 2 | 11913.87 | 12531.45 | 10% | | Lyophilisat und Lösungsmittel: Sotaterceptum 45 mg | MSD Merck Sharp & Dohme AG | B / SL | FB | | G |  |
L | | FI | | | Winrevair 60 mg | | 7942.58 | 8456.90 | 10% | | Lyophilisat und Lösungsmittel: Sotaterceptum 60 mg | MSD Merck Sharp & Dohme AG | B / SL | FB | | G |  |
L | | FI | | | Winrevair 60 mg | 2 | 15885.16 | 16605.95 | 10% | | Lyophilisat und Lösungsmittel: Sotaterceptum 60 mg | MSD Merck Sharp & Dohme AG | B / SL | FB | | G |  |
|
L | | FI | PI | | Yuvanci 10 mg/40 mg | 30 | 2736.57 | 2992.60 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
|
| | | PI | H | Co-Hypert | 100 ml | PA | 27.20 | k.A. | | Tropfen zum Einnehmen: 7 Wirkstoffe | ebi-pharm ag | B | FB | | G |  |